Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry A Casey

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
Plos One|January 26, 2019
Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategyReena Varkey, Qun Du, Jodi L Karnell, et al.
ACR Open Rheumatology|March 23, 2026
Distinct Interferon and Intracellular Signaling Signatures in Systemic Lupus Erythematosus and Dermatomyositis by Integrative Transcriptomic and Proteomic AnalysisJames M Ward, Mythri Ambatipudi, Zerai Manna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissuesKerry A Casey, Kathryn A Fraser, Jason M Schenkel, et al.
Arthritis Research & Therapy|November 11, 2024
Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositisA Clare Sparling, James M Ward, Kakali Sarkar, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosusSaifur Rahman, Divya Sagar, Richard N Hanna, et al.
Mabs|July 8, 2025
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligandAnnie Lau-Kilby, Michele Gunsior, Agata Bartczak, et al.
Scientific Reports|October 10, 2019
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid LupusMichael A Smith, Jill Henault, Jodi L Karnell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 25, 2023
Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile DermatomyositisJames M Ward, Mythri Ambatipudi, Terrance P O'Hanlon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus ErythematosusKerry A Casey, Michael A Smith, Dominic Sinibaldi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
Plos One|January 26, 2019
Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategyReena Varkey, Qun Du, Jodi L Karnell, et al.
ACR Open Rheumatology|March 23, 2026
Distinct Interferon and Intracellular Signaling Signatures in Systemic Lupus Erythematosus and Dermatomyositis by Integrative Transcriptomic and Proteomic AnalysisJames M Ward, Mythri Ambatipudi, Zerai Manna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissuesKerry A Casey, Kathryn A Fraser, Jason M Schenkel, et al.
Arthritis Research & Therapy|November 11, 2024
Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositisA Clare Sparling, James M Ward, Kakali Sarkar, et al.
Annals of the Rheumatic Diseases|May 2, 2019
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosusSaifur Rahman, Divya Sagar, Richard N Hanna, et al.
Mabs|July 8, 2025
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligandAnnie Lau-Kilby, Michele Gunsior, Agata Bartczak, et al.
Scientific Reports|October 10, 2019
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid LupusMichael A Smith, Jill Henault, Jodi L Karnell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 25, 2023
Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile DermatomyositisJames M Ward, Mythri Ambatipudi, Terrance P O'Hanlon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2020
Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus ErythematosusKerry A Casey, Michael A Smith, Dominic Sinibaldi, et al.
Pageof 3